Pharmaceutical Industries Ltd.
Your browser does not support iframes.
See Teva's sites around the world
Japan & S. Korea
Bosnia & Herzegovina
Want to find out more about Teva's locations and phone numbers?
Visit Teva Worldwide
Board of Directors
2016 Annual Report on Form 20-F
Notice of Annual Meeting of Shareholders 2017 – Proxy Statement
Over the Counter (OTC)
Central Nervous System (CNS)
Teva at IATI BIOMED 2015
Leading the Fight for Cures
National Network of Excellence
Position on Antimicrobial Resistance (AMR)
2015 CSR Communication on Progress
Previous CSR Reports
Supplier Code of Conduct & Information for Our Suppliers
Global Patient Organization and Advocacy Disclosure
Teva Fact Sheet
Four New Independent Directors Join the Teva Board
Webcasts and Presentations
Grow with the Best
Our Guiding Values
Grow with the Best
Go to Parent
R&D at Teva is different. We don’t just develop new medicines; we look beyond the drug and apply a holistic approach to the development of new treatment solutions that focus on the needs of patients and the people who care for them.
Share on Facebook
Share on LinkedIn
Our approach looks not just at managing a particular disease or specific symptom but also looks at how a treatment fits into the lives of patients – how they take the drug, where, how often and what the impact of that treatment is.
This holistic approach requires the thinking, skills and insights of a range of talented and caring people and precise expertise. And it requires a different way of doing things.
Our Global R&D is the only truly integrated R&D group in the industry, working across new specialty medicines, innovation around existing molecules, generics and OTC (over-the-counter) medicines.
Our Integrated Approach to R&D
This unique structure brings fresh thinking, different perspectives and broader knowledge into our research and development process. It encompasses our expertise in devices, in formulation and in analytics. These are combined with deep therapeutic understanding and outstanding clinical and non-clinical development skills. Together, this enables us to create new treatments that integrate better with patients’ needs and ultimately make life better.
You May Also Like...
National Health Service (NHS) UK
South Korean Delegation Visits Teva
Chinese Deputy Minister Visits Teva at Kfar Saba, Israel